Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 7 - Drugs for disorders of the blood or the extracellular fluid
Patents for A61P 7 - Drugs for disorders of the blood or the extracellular fluid (67,065)
06/2008
06/24/2008US7390625 Apoptosis-associated protein and use thereof
06/24/2008US7390519 Probiotic Lactobacillus salivarius strains
06/24/2008US7390488 Administering platelet binding agent; complexing; activation of complex; thrombosis
06/19/2008WO2008073670A2 Unit dose formulations and methods of treating thrombosis with an oral factor xa inhibitor
06/19/2008WO2008073395A2 Compositions and methods for cardiac tissue protection and regeneration
06/19/2008WO2008072850A1 Triazine derivatives having inhibitory activity against acetyl-coa carboxylase
06/19/2008WO2008072779A1 Quinoxaline derivative
06/19/2008WO2008072726A1 1-phenyl 1-thio-d-glucitol derivative
06/19/2008WO2008072682A1 Imidazo[1,2-b]pyridazine derivative
06/19/2008WO2008072591A1 Iron metabolism-improving agent
06/19/2008WO2008072535A1 Pharmaceutical composition containing low-substituted hydroxypropylcellulose
06/19/2008WO2008072534A1 Solid medicinal preparation containing mannitol or lactose
06/19/2008WO2008072533A1 Method for producing solid preparation
06/19/2008WO2008072532A1 Pharmaceutical composition having improved storage stability
06/19/2008WO2008071081A1 Preparation of low bleeding anticoagulant fusion protein and its use
06/19/2008WO2008050139A3 Laminin binding site
06/19/2008WO2008045566B1 Methods for dosing an orally active 1,2,4-oxadiazole for nonsense mutation suppression therapy
06/19/2008WO2008009894A3 Use of imino sugars in immunotherapy
06/19/2008WO2007127298A3 Pucoidans for reducing blood coagulation
06/19/2008WO2007121447A3 Use of opioid antagonists to attenuate endothelial cell proliferation and migration
06/19/2008WO2006078621A9 2-phenoxy-n- (1, 3 , 4-thiadizol-2-yl) pyridin-3-amine derivatives and related compounds as p2y1 receptor inhibitors for the treatment of thromboembolic disorders
06/19/2008US20080146639 Reducing the incidence of fibrosis by the co-administration of effective amounts of telmisartan and ramipril; strokes; cardiovascular disorders; organoprotective, tissue-protective, and vasculoprotective effects of combined treatment
06/19/2008US20080146594 Thrombopoietin activity modulating compounds and methods
06/19/2008US20080146503 albumin fusion proteins. Nucleic acid molecules encoding the albumin fusion proteins of the invention are also encompassed by the invention, as are vectors containing these nucleic acids, host cells transformed with these nucleic acids vectors, and methods of making the albumin fusion proteins
06/19/2008US20080145410 An iron-containing complex to treat hyperphosphatemia by adsorbing excess phosphates in the blood; capacity of >140 mg adsorbed phosphate by 1 g complex of an insoluble carbohydrate (starch), polynuclear iron oxide/hydroxide and a soluble glucose; stability; packaging; industrial scale
06/19/2008CA2672176A1 1-phenyl 1-thio-d-glucitol derivative
06/19/2008CA2672157A1 Method for producing solid preparation
06/19/2008CA2672154A1 Pharmaceutical composition having improved storage stability
06/19/2008CA2672134A1 Solid medicinal preparation containing mannitol or lactose
06/19/2008CA2671980A1 Quinoxaline derivatives
06/19/2008CA2671979A1 Pharmaceutical composition containing low-substituted hydroxypropyl cellulose
06/19/2008CA2671502A1 Unit dose formulations and methods of treating thrombosis with an oral factor xa inhibitor
06/18/2008EP1932911A1 Promoter for introducing gene into lymphocyte or blood cell and application thereof
06/18/2008EP1932529A1 Method of improved diuresis in individuals with impaired renal function
06/18/2008EP1931694A1 Aptamers comprising arabinose modified nucleotides
06/18/2008EP1443937B1 Substituted 1,4-benzodiazepines and uses thereof for the treatment of cancer
06/18/2008EP1228203B1 Peptide (virip) which inhibits a circulating virus in humans and the use thereof
06/18/2008CN101203607A Anti-CD-20 monoclonal antibody
06/18/2008CN101203512A Heterocyclic compound
06/18/2008CN101203485A Amide derivative, pesticide containing such compound and use thereof
06/18/2008CN101203223A Pharmaceutical composition comprising amorphous rosiglitazone
06/18/2008CN101200708A Mouse anti-human CD14 monoclonal antibody hybridoma cell line, monoclonal antibody, immunohistochemical reagent kit and uses thereof
06/18/2008CN101200501A Technique for modifying human cord blood hemoglobin alpha-chain by bis(3,5-dibromo salicyl) fumaric acid esters
06/18/2008CN101200493A (3S)-N-(L-aminoacyl)-1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid, preparation method and uses thereof
06/18/2008CN101200466A Heterocyclic compounds having antithrombotic activity, preparation method and uses thereof
06/18/2008CN101199853A Bloodvesselofbrain endodermis cell target polylactic acid nanometer particle carrier, producing method and application thereof
06/18/2008CN101199827A Healthy heart capsule
06/18/2008CN101199775A Oral administration Chinese medicine for treating qi adverseness blood silt hemoptysis
06/18/2008CN101199754A Medicament for treating trauma bleeding, body surface and part cavity film inflammation and preparing method thereof
06/18/2008CN101199753A Oral administration Chinese medicine for treating dryness-heat cough hemoptysis
06/18/2008CN101199752A Oral administration Chinese medicine for treating haemostasis retained hematemesis
06/18/2008CN101199748A Chinese medicine preparation for treating hematonosis
06/18/2008CN101199724A Oral administration Chinese medicine for treating liver stomach discord type hematemesis
06/18/2008CN101199655A Chinese medicine agent for treating after medicament abortion uterus bleeding
06/18/2008CN101199595A Extractive process of baical skullcap root active ingredient
06/18/2008CN101199592A Compound ginkgo agent for preventing and treating cardiovascular system disease
06/18/2008CN101199586A Medicament for purpruick
06/18/2008CN101199571A Yunnan and Guangxi Einar sweet syrup preparing method and detective method thereof
06/18/2008CN101199556A Recipient beta-blocker of prevention weaning piggy diarrhea and piggy oedematous disease, preparing and application
06/18/2008CN101199548A Perfluorination carbon emulsion and preparing method thereof
06/18/2008CN101199540A Polygonin sheet dose and preparing method thereof
06/18/2008CN101199538A Fructose two-phosphoric acid Na capsule and preparing method thereof
06/18/2008CN100394981C Human granulocyte-macrophage colony stimulating factor spray and its preparation process
06/18/2008CN100394915C Use of gingerol oxime in preparing anti-blood platelet aggregation medicine
06/17/2008US7388075 Medicament containing activated antithrombin III
06/17/2008US7388030 Suppressors of anemia and appetite suppressors and methods for suppressing anemia and suppressing appetite
06/17/2008US7387777 Methods of treating hemophilia or von willebrand disease with p-selectin
06/17/2008CA2393749C Substituted 8-arylquinoline phosphodiesterase-4 inhibitors
06/17/2008CA2294457C Pharmaceutical composition for application to mucosa
06/17/2008CA2261762C Substituted 2(2,6-dioxopiperidin-3-yl)phthalimides and -1-oxoisoindolines and method of reducing tnf-alpha levels
06/17/2008CA2253113C Carbohydrate derivatives
06/17/2008CA2186497C Factor xa inhibitors
06/17/2008CA2067250C Inhibition of padgem-mediated cell binding
06/12/2008WO2008069262A1 Film-coated preparation having improved stability
06/12/2008WO2008068475A1 New crystalline forms
06/12/2008WO2008067871A1 Substituted dihydropyrazolones for treating cardiovascular and haematological diseases
06/12/2008WO2008067756A1 3-pyrrolo-cyclohexylene-2-dihydro-indolinone derivatives and uses thereof
06/12/2008WO2008067609A1 Method and composition for reducing reperfusion injury
06/12/2008WO2008038175A3 Dithiolopyrrolones compounds and their therapeutic applications
06/12/2008US20080140138 Inhibition of inflammatory cytokine production by stimulation of brain muscarinic receptors
06/12/2008US20080139636 Adamantane derivatives
06/12/2008US20080139604 Administering nicotinic acid and/or prostaglandin D2 receptor agonist; simvastatins; eliminates flushing
06/12/2008US20080139489 Use of ketolides for preventing arterial thrombotic complications related to atherosclerosis
06/12/2008US20080139470 Erythropoietin compositions
06/12/2008US20080138315 Using expression vector comprising UDP-glucuronosyltransferase (UGTIAI) as gene transfer tool in treatment of hyperbilirubinemia
06/12/2008CA2671975A1 Film-coated preparation having improved stability
06/12/2008CA2670678A1 New crystalline forms
06/12/2008CA2669735A1 Methods of treating hemolytic anemia
06/11/2008EP1930322A1 1-(4-piperidinyl)-1,3-dihydro-2H-benzoxazole-2-one derivatives and related compounds as nociceptin analogs and ORL1 ligands for the treatment of pain
06/11/2008EP1930021A2 Novel amide derivatives as growth hormone secretagogues
06/11/2008EP1930000A1 Combination of organic compounds
06/11/2008EP1929860A1 Transgenic avian which has foreign gene containing sequence encoding feline-derived protein and method for production thereof
06/11/2008EP1928867A1 2-aminoethoxyacetic acid derivatives and their use in treating thromboembolic disorders
06/11/2008EP1928864A1 Novel cycloalkane carboxamides as factor xa inhibitors
06/11/2008EP1928505A2 Aptamers that bind thrombin with high affinity
06/11/2008EP1928414A2 Production of emulsions for intravenous injection of water-insoluble pharmaceutical compositions
06/11/2008CN101198614A Thienopyrimidine derivative
06/11/2008CN101198341A Antipyrotic
06/11/2008CN101198321A Hematopoietic factor production promoter
06/11/2008CN101195659A High anticoagulating active antihuman tissue factor monoclone antibody, preparation method and application thereof
1 ... 213 214 215 216 217 218 219 220 221 222 223 224 225 226 227 228 229 230 231 232 233 ... 671